Topic prioritisation
Showing 1 to 1 of 1
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199] | None selected | Not selected |